Sulfated glycosaminoglycan-assisted receptor specificity of human fibroblast growth factor (FGF) 19 signaling in a mouse system is different from that in a human system

Journal of Biomolecular Screening

Volumn 18, Issue 3, 2013, Pages 321-330

  Nakamura, Masao ^a,b,c   Uehara, Yuriko ^a   Asada, Masahiro ^a   Suzuki, Masashi ^a,b   Imamura, Toru ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b IBARAKI UNIVERSITY   (Japan)

^c RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

assay; FGF19; human; mouse; receptor specificity

Indexed keywords

FIBROBLAST GROWTH FACTOR 19; FIBROBLAST GROWTH FACTOR 4; GLYCOSAMINOGLYCAN; HEPARIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSGENIC ANIMAL;

ANIMALS; CELL LINE, TUMOR; FIBROBLAST GROWTH FACTORS; HEPARIN; HUMANS; LIVER; MICE; MICE, TRANSGENIC; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 4; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION;

EID: 84873659421     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057112463820     Document Type: Article

References (34)

1. Itoh N., Ornitz D. M.. Evolution of the Fgf and Fgfr Gene Families. Trends Genet. 2004 ; 20: 563-569 (Pubitemid 39314564)
2. Jones S.. Mini-Review: Endocrine Actions of Fibroblast Growth Factor 19. Mol. Pharm. 2008 ; 5: 42-48 (Pubitemid 351300033)
3. Wu X., Li Y.. Therapeutic Utilities of Fibroblast Growth Factor 19. Expert Opin. Ther. Targets. 2011 ; 11: 1307-1316
4. Lundåsen T., Gälman C., Angelin B., Rudling M.. Circulating Intestinal Fibroblast Growth Factor 19 Has a Pronounced Diurnal Variation and Modulates Hepatic Bile Acid Synthesis in Man. J. Intern. Med. 2006 ; 260: 530-536 (Pubitemid 44772372)
5. Nishimura T., Utsunomiya Y., Hoshikawa M., Ohuchi H., Itoh N.. Structure and Expression of a Novel Human FGF, FGF-19, Expressed in the Fetal Brain. Biochim. Biophys. Acta. 1999 ; 1: 148-151 (Pubitemid 29092864)
6. Wright T. J., Ladher R., McWhirter J., Murre C., Schoenwolf G. C., Mansour S. L.. Mouse FGF15 Is the Ortholog of Human and Chick FGF19, But Is Not Uniquely Required for Otic Induction. Dev. Biol. 2004 ; 1: 264-275 (Pubitemid 38471838)
7. Inagaki T., Choi M., Moschetta A., Peng L., Cummins C. L., McDonald J. G., Luo G., Jones S. A., Goodwin B., Richardson J. A., Gerard R. D., Repa J. J., Mangelsdorf D. J., Kliewer S. A.. Fibroblast Growth Factor 15 Functions as an Enterohepatic Signal to Regulate Bile Acid Homeostasis. Cell Metab. 2005 ; 2: 217-225
8. Tomlinson E., Fu L., John L., Hultgren B., Huang X., Renz M., Stephan J. P., Tsai S. P., Powell-Braxton L., French D., Stewart T. A.. Transgenic Mice Expressing Human Fibroblast Growth Factor-19 Display Increased Metabolic Rate and Decreased Adiposity. Endocrinology. 2002 ; 143: 1741-1747 (Pubitemid 34415889)
9. Fu L., John L. M., Adams S. H., Yu X. X., Tomlinson E., Renz M., Williams P. M., Soriano R., Corpuz R., Moffat B., Vandlen R., Simmons L., Foster J., Stephan J. P., Tsai S. P., Stewart T. A.. Fibroblast Growth Factor 19 Increases Metabolic Rate and Reverses Dietary and Leptin-Deficient Diabetes. Endocrinology. 2004 ; 145: 2594-2603 (Pubitemid 38686202)
10. Tomiyama K., Maeda R., Urakawa I., Yamazaki Y., Tanaka T., Ito S., Nabeshima Y., Tomita T., Odori S., Hosoda K., Nakao K., Imura A., Nabeshima Y.. Relevant Use of Klotho in FGF19 Subfamily Signaling System In Vivo. Proc. Natl. Acad. Sci. U. S. A. 2010 ; 107: 1666-1671
11. Lin B. C., Wang M., Blackmore C., Desnoyers L. R.. Liver-Specific Activities of FGF19 Require Klotho Beta. J. Biol. Chem. 2007 ; 282: 27277-27284 (Pubitemid 47501977)
12. Suzuki M., Uehara Y., Motomura-Matsuzaka K., Oki J., Koyama Y., Kimura M., Asada M., Komi-Kuramochi A., Oka S., Imamura T.. βKlotho Is Required for Fibroblast Growth Factor (FGF) 21 Signaling through FGF Receptor (FGFR) 1c and FGFR3c. Mol. Endocrinol. 2008 ; 22: 1006-1014 (Pubitemid 351482834)
13. Shimamoto G., Stevens J., Hawkins N., Lemon B., Shen W., Xu J., Veniant M. M., Li Y.-S., Lindberg R., Chen J.-L., Tian H., Li Y.. Co-receptor Requirements for Fibroblast Growth Factor-19 Signaling. J. Biol. Chem. 2007 ; 282: 29069-29072 (Pubitemid 350043330)
14. Wu X., Lemon B., Li X. F., Gupte J., Weiszmann J., Stevens J., Hawkins N., Shen W., Lindberg R., Chen J.-L., Tian H., Li Y.. C-Terminal Tail of FGF19 Determines Its Specificity Toward Klotho Co-receptors. J. Biol. Chem. 2008 ; 283: 33304-33309
15. Nakamura M., Uehara Y., Asada M., Honda E., Nagai N., Kimata K., Suzuki M., Imamura T.. Sulfated Glycosaminoglycans Are Required for Specific and Sensitive Fibroblast Growth Factor (FGF) 19 Signaling via FGF Receptor 4 and betaKlotho. J. Biol. Chem. 2011 ; 286: 26418-26423
16. Xiea M. H., Holcomb I., Deuela B., Dowda P., Huanga A., Vagtsa A., Fostera J., Lianga J., Brusha J., Gua Q., Hillana K., Goddarda A., Gurney A. L.. FGF-19, a Novel Fibroblast Growth Factor with Unique Specificity for FGFR4. Cytokine. 1999 ; 11: 729-735 (Pubitemid 29460470)
17. Desnoyers L. R., Pai R., Ferrando R. E., Hötzel K., Le T., Ross J., Carano R., D'Souza A., Qing J., Mohtashemi I., Ashkenazi A., French D. M.. Targeting FGF19 Inhibits Tumor Growth in Colon Cancer Xenograft and FGF19 Transgenic Hepatocellular Carcinoma Models. Oncogene. 2008 ; 27: 85-97
18. Nicholes K., Guillet S., Tomlinson E., Hillan K., Wright B., Frantz G. D., Pham T. A., Dillard-Telm L., Tsai S. P., Stephan J. P., Stinson J., Stewart T., French D. M.. A Mouse Model of Hepatocellular Carcinoma: Ectopic Expression of Fibroblast Growth Factor 19 in Skeletal Muscle of Transgenic Mice. Am. J. Pathol. 2002 ; 160: 2295-2307 (Pubitemid 34663420)
19. Wu X., Ge H., Lemon B., Vonderfecht S., Baribault H., Weiszmann J., Gupte J., Gardner J., Lindberg R., Wang Z., Li Y.. Separating Mitogenic and Metabolic Activities of Fibroblast Growth Factor 19 (FGF19). Proc. Natl. Acad. Sci. U. S. A. 2010 ; 107: 14158-14163
20. Wu X., Ge H., Lemon B., Weiszmann J., Gupte J., Hawkins N., Li X., Tang J., Lindberg R., Li Y.. Selective Activation of FGFR4 by an FGF19 Variant Does Not Improve Glucose Metabolism in ob/ob Mice. Proc. Natl. Acad. Sci. U. S. A. 2009 ; 106: 14379-14384
21. Wu X., Ge H., Lemon B., Vonderfecht S., Weiszmann J., Hecht R., Gupte J., Hager T., Wang Z., Lindberg R., Li Y.. FGF19-Induced Hepatocyte Proliferation Is Mediated through FGFR4 Activation. J. Biol. Chem. 2010 ; 285: 5165-5170
22. Yoneda A., Asada M., Oda Y., Suzuki M., Imamura T.. Engineering of an FGF-Proteoglycan Fusion Protein with Heparin-Independent, Mitogenic Activity. Nat. Biotechnol. 2000 ; 18: 641-644 (Pubitemid 30415298)
23. Zhang X., Ibrahimi O. A., Olsen S. K., Umemori H., Mohammadi M., Ornitz D. M.. Receptor Specificity of the Fibroblast Growth Factor Family: The Complete Mammalian FGF Family. J. Biol. Chem. 2006 ; 281: 15694-15700 (Pubitemid 43848456)
24. Allen B. L., Rapraeger A. C.. Spatial and Temporal Expression of Heparan Sulfate in Mouse Development Regulates FGF and FGF Receptor Assembly. J. Cell Biol. 2003 ; 3: 637-648 (Pubitemid 37429875)
25. Kurosu H., Choi M., Ogawa Y., Dickson A. S., Goetz R., Eliseenkova A. V., Mohammadi M., Rosenblatt K. P., Kliewer S. A., Kuro-o M.. Tissue-Specific Expression of βKlotho and Fibroblast Growth Factor (FGF) Receptor Isoforms Determines Metabolic Activity of FGF19 and FGF21. J. Biol. Chem. 2007 ; 282: 26687-26695 (Pubitemid 47501965)
26. Kir S., Beddow S. A., Samuel V. T., Miller P., Previs S. F., Suino-Powell K., Xu H. E., Shulman G. I., Kliewer S. A., Mangelsdorf D. J.. FGF19 as a Postprandial, Insulin-Independent Activator of Hepatic Protein and Glycogen Synthesis. Science. 2011 ; 331: 1621-1624
27. Potthoff M. J., Boney-Montoya J., Choi M., He T., Sunny N. E., Satapati S., Suino-Powell K., Xu H. E., Gerard R. D., Finck B. N., Burgess S. C., Mangelsdorf D. J., Kliewer S. A.. FGF15/19 Regulates Hepatic Glucose Metabolism by Inhibiting the CREB-PGC-1α Pathway. Cell Metab. 2011 ; 6: 729-738
28. Fon Tacer K., Bookout A. L., Ding X., Kurosu H., John G. B., Wang L., Goetz R., Mohammadi M., Kuro-o M., Mangelsdorf D. J., Kliewer S. A.. Research Resource: Comprehensive Expression Atlas of the Fibroblast Growth Factor System in Adult Mouse. Mol. Endocrinol. 2010 ; 10: 2050-2064
29. Choi M., Moschetta A., Bookout A.L., Peng L., Umetani M., Holmstrom S. R., Suino-Powell K., Xu H. E., Richardson J. A., Gerard R. D., Mangelsdorf D. J., Kliewer S. A.. Identification of a Hormonal Basis for Gallbladder Filling. Nat. Med. 2006 ; 11: 1253-1255 (Pubitemid 44706926)
30. Luo Y., Yang C., Lu W., Xie R., Jin C., Huang P., Wang F., McKeehan W. L.. Metabolic Regulator βKlotho Interacts with Fibroblast Growth Factor Receptor 4 (FGFR4) to Induce Apoptosis and Inhibit Tumor Cell Proliferation. J. Biol. Chem. 2010 ; 285: 30069-30078
31. Asada M., Shinomiya M., Suzuki M., Honda E., Sugimoto R., Ikekita M., Imamura T.. Glycosaminoglycan Affinity of the Complete Fibroblast Growth Factor Family. Biochim. Biophys. Acta. 2009 ; 1: 40-48
32. Goetz R., Beenken A., Ibrahimi O. A., Kalinina J., Olsen S. K., Eliseenkova A. V., Xu C., Neubert T. A., Zhang F., L inhardt R. J., Yu X., White K. E., Inagaki T., Kliewer S. A., Yamamoto M., Kurosu H., Ogawa Y., Kuro-o M., Lanske B., Razzaque M. S., Mohammadi M.. Molecular Insights into the Klotho-Dependent, Endocrine Mode of Action of Fibroblast Growth Factor 19 Subfamily Members. Mol. Cell Biol. 2007 ; 9: 3417-3428 (Pubitemid 46685217)
33. Sugaya N., Habuchi H., Nagai N., Ashikari-Hada S., Kimata K.. 6-O-Sulfation of Heparan Sulfate Differentially Regulates Various Fibroblast Growth Factor-Dependent Signalings in Culture. J. Biol. Chem. 2008 ; 283: 10366-10376
34. Shi X., Zaia J.. Organ-Specific Heparan Sulfate Structural Phenotypes. J. Biol. Chem. 2009 ; 284: 11806-11814